Drugs / Cocarboxylase

Trials 0

Also used as a comparator or background therapy in 1 trial
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 4 NCT07296354 Comparator Jan 2026 → Feb 2028 expected neuropathy, painful Egyptian International Pharmaceutical Industries Co Not yet recruiting No outcome recorded

Evidence & citations 10 cited values

Every value below carries the sentence it was read from. 2 sources stand behind the page.

FieldValueCited text
Known as Cocarboxylase Cocarboxylase (Vitamin B1 derivative) - 50 mg Nicotinamide (Vitamin B3) - 20 mg Vitamin B12 (Cyanocobalamin) - 500 mcg” NCT07296354
Known as Cocarboxilasa ChEMBL registry synonym — accepted as the source's own label CHEMBL1236376
Known as Cocarboxylase chloride ChEMBL registry synonym — accepted as the source's own label CHEMBL1236376
Known as Cocarboxylase hydrochloride ChEMBL registry synonym — accepted as the source's own label CHEMBL1236376
Known as Coenzymate ChEMBL registry synonym — accepted as the source's own label CHEMBL1236376
Known as Pyrophosphoric ester of thiamine ChEMBL registry synonym — accepted as the source's own label CHEMBL1236376
Known as Thiamine diphosphate ChEMBL registry synonym — accepted as the source's own label CHEMBL1236376
Known as Thiamine pyrophosphate ChEMBL registry synonym — accepted as the source's own label CHEMBL1236376
Known as Thiamine pyrophosphate chloride ChEMBL registry synonym — accepted as the source's own label CHEMBL1236376
Modality Small molecule CHEMBL1236376